Abstract
Lower-dose diclofenac capsules developed using solumatrix fine particle technology result in clinically meaningful improvements in pain in a phase 3 study of patients with osteoarthritis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have